Denise Scots-Knight, Mereo BioPharma CEO
August 22, 2022 10:59 AM EDT
Financing

Mere­o's biggest share­hold­er eyes ma­jor changes amid stock falloff

Tyler Patchen

News Reporter

UK-based biotech Mereo Bio­Phar­ma is fac­ing some heat from one of its prin­ci­pal share­hold­ers as it looks to make sev­er­al changes to the biotech’s board …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

As blue­bird projects more com­mer­cial de­mand, the biotech con­tin­ues to seek cash

Zai Lab aims to raise $200M; Kro­nos Bio to seek ‘strate­gic’ op­tions

Ex­clu­sive: As­cid­i­an CEO Michael Ehlers leaves Ap­ple Tree Part­ners for MPM BioIm­pact

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times